Indian Court Allows Dr. Reddy's to Produce Generic Versions of Novo Nordisk's Semaglutide Drugs

An Indian court has allowed Dr. Reddy's Laboratories to manufacture and export generic versions of Novo Nordisk's semaglutide, the key ingredient in Ozempic and Wegovy. The decision comes as the patent for semaglutide is set to expire in India early next year, paving the way for cheaper generic versions to be sold in various markets. Novo Nordisk has the option to appeal to the Supreme Court.